Skip to main content
AlzChem Group AG logo

AlzChem Group AG — Investor Relations & Filings

Ticker · ACT ISIN · DE000A2YNT30 LEI · 8945004EL7WZK3ERG181 F Manufacturing
Open in API
Filings indexed 414 across all filing types
Latest filing 2025-06-24 AGM Information
Country DE Germany
Listing F ACT

About AlzChem Group AG

https://www.alzchem.com/en

AlzChem Group AG is a globally active, vertically integrated specialty chemicals company focused on NCN (Nitrogen-Carbon-Nitrogen) chemistry. Its production chain is based on raw materials such as calcium carbide and calcium cyanamide, from which it develops a wide range of products. The company serves diverse markets including human and animal nutrition, pharmaceuticals, agriculture, metallurgy, renewable energy, and automotive. Key products include high-purity creatine for dietary supplements (Creapure®), feed additives for animal nutrition (Creamino®), and high-purity guanidine salts used as intermediates for pharmaceutical and diagnostic applications, such as PCR tests. AlzChem also offers custom synthesis services and is a market leader in many of its business segments.

Recent filings

Filing Released Lang Actions
Ergänzung der Veröffentlichung vom 18.03.2025
AGM Information Classification · 99% confidence The document text explicitly mentions 'Jahresabschluss zum Geschäftsjahr vom 01.01.2024 bis zum 31.12.2024' (Annual Financial Statements for the fiscal year ending 12/31/2024) and details the 'Beschluss über die Verwendung des Bilanzgewinns' (Resolution on the appropriation of the retained earnings) decided by the 'Hauptversammlung' (General Meeting). This resolution includes the specific dividend payout amount (EUR 1.80 per share) and the resulting retained earnings carry-forward. Since the core content is the formal decision regarding the allocation of the annual profit/dividend following the annual financial review, it strongly relates to the outcome of the annual reporting cycle and shareholder decisions. However, the primary focus here is the dividend decision itself, which is a specific corporate action. The closest fit among the provided codes is 'DIV' (Notice of Dividend Amount), as the document details the exact dividend amount approved by the AGM based on the annual results. While it references the annual results, the actionable item communicated is the dividend.
2025-06-24 German
Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - 11th interim report
Transaction in Own Shares Classification · 100% confidence The document is a short corporate news release dated June 23, 2025, titled 'Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 – 11th interim report'. The content details the acquisition of shares by the company as part of a share buyback programme during the period June 16th to June 20th, 2025. This is a specific regulatory disclosure concerning insider/executive transactions related to share repurchase activity. The definition for 'Transaction in Own Shares' (POS) covers reports of the company buying back shares. Although it mentions an 'Interim Report' in the title, the body is exclusively about the buyback transaction details, not a comprehensive financial report. Therefore, POS is the most appropriate classification.
2025-06-23 English
Major Shareholding Notification 2025
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'Notification of Major Holdings' and details the acquisition/disposal of shares with voting rights by JPMorgan Asset Management (UK) Limited concerning Alzchem Group AG. It reports specific percentages of voting rights (5.09%) and the date the threshold was crossed (16 Jun 2025). This type of filing, concerning changes in significant share ownership thresholds, directly corresponds to the definition of Major Shareholding Notification (MRQ). The document mentions compliance with WpHG (German Securities Trading Act), which is typical for such regulatory disclosures.
2025-06-20 English
Declaration of Voting Results & Voting Rights Announcements 2025
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Voting rights Announcements' and explicitly contains a 'Notification of Major Holdings' section, detailing changes in voting rights percentages (crossing thresholds) for a specific shareholder (JPMorgan Chase Bank, National Association) in Alzchem Group AG, referencing German Securities Trading Act (WpHG) sections. This content directly corresponds to the definition of reporting changes in significant share ownership levels, which maps to the Major Shareholding Notification category (MRQ). Although the header mentions 'Voting rights Announcements', the core content is the change in holding percentage, making MRQ more specific than DVA (Declaration of Voting Results) or RNS (General Regulatory Filing). The document is a formal regulatory disclosure of ownership change.
2025-06-18 English
Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - 10th interim report
Transaction in Own Shares Classification · 100% confidence The document is titled 'Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 – 10th interim report'. The content explicitly details the number of shares acquired as part of a 'share buyback programme' during a specific weekly period (June 9th to June 13th, 2025). A share buyback is a transaction where a company repurchases its own shares. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). Although it mentions an 'interim report', the substance is purely the transaction disclosure, not a comprehensive financial report (like IR or 10-K).
2025-06-16 English
Declaration of Voting Results & Voting Rights Announcements 2025
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting rights Announcements' and contains detailed tables regarding the 'Notification of Major Holdings' under German Securities Trading Act (WpHG). It details changes in the percentage of voting rights held by DWS Investment GmbH in Alzchem Group AG, specifically noting an 'Acquisition/disposal of shares with voting rights' and 'Equity collateral returned'. This content directly corresponds to reporting requirements for changes in significant share ownership thresholds, which maps precisely to the Major Shareholding Notification category.
2025-06-10 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.